{
  "success": true,
  "sourceFile": "input/Alexion_NCT04573309_Wilsons_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33
  ],
  "modelUsed": "gemini-2.5-pro",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened Set",
        "text": "The Screened Set includes all participants who signed an informed consent form (ICF).",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "label": "SS",
        "populationDescription": "The Screened Set includes all participants who signed an informed consent form (ICF)."
      },
      {
        "id": "pop_2",
        "name": "Enrolled Set",
        "text": "The Enrolled Set includes all participants who were enrolled in the study.",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "label": "ES",
        "populationDescription": "The Enrolled Set includes all participants who were enrolled in the study."
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set",
        "text": "The Full Analysis (FA) Set includes all enrolled participants who received at least 1 dose of study drug and have at least 1 post-Baseline efficacy assessment. The FA Set will be the primary analysis set for all efficacy analyses.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FAS",
        "populationDescription": "The Full Analysis (FA) Set includes all enrolled participants who received at least 1 dose of study drug and have at least 1 post-Baseline efficacy assessment. The FA Set will be the primary analysis set for all efficacy analyses."
      },
      {
        "id": "pop_4",
        "name": "Per Protocol Set",
        "text": "The Per Protocol (PP) Set is a subset of the FA Set who are compliant with the protocol and do not have any major protocol deviations that could affect the evaluation of the primary endpoint. Major protocol deviations will be identified and documented before database lock. The PP Set will be used for sensitivity analyses of the primary efficacy endpoint.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "populationDescription": "The Per Protocol (PP) Set is a subset of the FA Set who are compliant with the protocol and do not have any major protocol deviations that could affect the evaluation of the primary endpoint. Major protocol deviations will be identified and documented before database lock. The PP Set will be used for sensitivity analyses of the primary efficacy endpoint."
      },
      {
        "id": "pop_5",
        "name": "Safety Set",
        "text": "The Safety Set includes all participants who received at least 1 dose of study drug. All safety analyses will be performed using the Safety Set.",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "SAF",
        "populationDescription": "The Safety Set includes all participants who received at least 1 dose of study drug. All safety analyses will be performed using the Safety Set."
      },
      {
        "id": "pop_6",
        "name": "Pharmacokinetic Analysis Set",
        "text": "The Pharmacokinetic (PK) Analysis Set includes all participants in the Safety Set who have at least 1 evaluable post-dose plasma concentration measurement for ALXN1840. The PK Analysis Set will be used for all PK analyses.",
        "populationType": "PK/PD",
        "instanceType": "AnalysisPopulation",
        "label": "PK Set",
        "populationDescription": "The Pharmacokinetic (PK) Analysis Set includes all participants in the Safety Set who have at least 1 evaluable post-dose plasma concentration measurement for ALXN1840. The PK Analysis Set will be used for all PK analyses."
      },
      {
        "id": "pop_7",
        "name": "Pharmacodynamic Analysis Set",
        "text": "The Pharmacodynamic (PD) Analysis Set includes all participants in the Safety Set who have at least 1 evaluable post-dose PD measurement. The PD Analysis Set will be used for all PD analyses.",
        "populationType": "PK/PD",
        "instanceType": "AnalysisPopulation",
        "label": "PD Set",
        "populationDescription": "The Pharmacodynamic (PD) Analysis Set includes all participants in the Safety Set who have at least 1 evaluable post-dose PD measurement. The PD Analysis Set will be used for all PD analyses."
      }
    ],
    "characteristics": [],
    "summary": {
      "populationCount": 7,
      "characteristicCount": 0
    }
  }
}